ZA200706702B - Therapeutic combinations of manidi pine and a statin - Google Patents

Therapeutic combinations of manidi pine and a statin

Info

Publication number
ZA200706702B
ZA200706702B ZA200706702A ZA200706702A ZA200706702B ZA 200706702 B ZA200706702 B ZA 200706702B ZA 200706702 A ZA200706702 A ZA 200706702A ZA 200706702 A ZA200706702 A ZA 200706702A ZA 200706702 B ZA200706702 B ZA 200706702B
Authority
ZA
South Africa
Prior art keywords
manidi
statin
pine
therapeutic combinations
therapeutic
Prior art date
Application number
ZA200706702A
Other languages
English (en)
Inventor
Fogari Roberto
Dell Anna Carmen
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of ZA200706702B publication Critical patent/ZA200706702B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
ZA200706702A 2005-02-17 2006-02-06 Therapeutic combinations of manidi pine and a statin ZA200706702B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05003382 2005-02-17

Publications (1)

Publication Number Publication Date
ZA200706702B true ZA200706702B (en) 2008-11-26

Family

ID=36118210

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200706702A ZA200706702B (en) 2005-02-17 2006-02-06 Therapeutic combinations of manidi pine and a statin

Country Status (16)

Country Link
US (2) US20080070926A1 (xx)
EP (1) EP1848425B1 (xx)
JP (1) JP2008530153A (xx)
KR (1) KR20070111468A (xx)
CN (1) CN101115480A (xx)
AR (1) AR052914A1 (xx)
AT (1) ATE520397T1 (xx)
AU (1) AU2006215855A1 (xx)
BR (1) BRPI0607142A2 (xx)
CA (1) CA2597498A1 (xx)
EA (1) EA200701460A1 (xx)
ES (1) ES2369787T3 (xx)
MX (1) MX2007009779A (xx)
PE (1) PE20061242A1 (xx)
WO (1) WO2006087117A1 (xx)
ZA (1) ZA200706702B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2030025A2 (en) 2006-06-07 2009-03-04 Tethys Bioscience, Inc. Markers associated with arteriovascular events and methods of use thereof
WO2010102158A1 (en) * 2009-03-04 2010-09-10 Walter Howard Peschel Compositions and treatment regimes for reducing inflammation, end-organ injury, and/or systemic endotoxemia
JP6421535B2 (ja) * 2014-10-14 2018-11-14 日亜化学工業株式会社 発光装置及び表示部並びに制御回路

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GT199800126A (es) * 1997-08-29 2000-01-29 Terapia de combinacion.
US20050267197A1 (en) * 2004-05-25 2005-12-01 Roger Berlin Compositions containing policosanol and HMG-Co-A reductase inhibitor and their pharmaceutical uses

Also Published As

Publication number Publication date
CA2597498A1 (en) 2006-08-24
ES2369787T3 (es) 2011-12-07
CN101115480A (zh) 2008-01-30
US20080070926A1 (en) 2008-03-20
EP1848425B1 (en) 2011-08-17
MX2007009779A (es) 2007-09-26
ATE520397T1 (de) 2011-09-15
AU2006215855A1 (en) 2006-08-24
WO2006087117A1 (en) 2006-08-24
AR052914A1 (es) 2007-04-11
EP1848425A1 (en) 2007-10-31
PE20061242A1 (es) 2006-12-21
KR20070111468A (ko) 2007-11-21
US20100022556A1 (en) 2010-01-28
EA200701460A1 (ru) 2008-02-28
BRPI0607142A2 (pt) 2009-08-11
JP2008530153A (ja) 2008-08-07

Similar Documents

Publication Publication Date Title
HK1258903A1 (zh) 抗-連接蛋白化合物及其治療應用
EP1833482A4 (en) COMPOUNDS AND ITS THERAPEUTIC USE
EP1781689A4 (en) CONJUGATES AND THEIR THERAPEUTIC APPLICATIONS
EP1853199A4 (en) DEVICES AND KIT FOR IMPROVING THE OPERATION OF A HEART VALVE
EP1887008A4 (en) THIENOTRIAZOLODIAZEPINE COMPOUND AND A MEDICAL APPLICATION THEREOF
IL191356A0 (en) Therapeutic materials
IL189165A0 (en) Novel formulations comprising fenofibrate and a statin, and related methods of treatment
IL179236A (en) Griffithsin and its antiviral resistant glycosylation variants and related methods
GB0619979D0 (en) Novel hydroxamates as therapeutic agents
IL177155A0 (en) Therapeutic combinations
ZA200701527B (en) Composition comprising statin
EP1838288A4 (en) THERAPEUTIC MATERIALS AND METHODS
GB0413068D0 (en) Treatment of pulp
GB0417481D0 (en) Combination therapy
GB0428180D0 (en) Combination therapy
MY143527A (en) Wood treatment
GB0424339D0 (en) Combination therapy
ZA200706702B (en) Therapeutic combinations of manidi pine and a statin
EP2097085A4 (en) THERAPEUTIC MATERIALS AND METHOD
GB0804039D0 (en) Anti-malarial composition comprising artesunate and lumefantrine
HK1097495A1 (en) Can body and can
GB0501052D0 (en) Curb set and match
GB0417558D0 (en) Novel combination therapy
AP2525A (en) Antimarial therapy using a combination of synthetic artemisinin derivative and bisquinoline derivative
IL185575A0 (en) Benzoxazocines and their therapeutic use